Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Matthew Alsaloum, M.D., Ph.D.

Concepts (51)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Matthew Alsaloum's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Matthew Alsaloum has written about over time.
Green Fluorescent Proteins, 1 publications between 2016 and 2016, average publication date February 2016. Mutagenesis, 1 publications between 2016 and 2016, average publication date February 2016. Receptors, Ionotropic Glutamate, 1 publications between 2016 and 2016, average publication date February 2016. Diabetic Neuropathies, 1 publications between 2019 and 2019, average publication date January 2019. Neuralgia, 1 publications between 2019 and 2019, average publication date January 2019. Sodium Channel Blockers, 1 publications between 2020 and 2020, average publication date October 2020. Ganglia, Spinal, 5 publications between 2019 and 2023, average publication date June 2021. Pain, 4 publications between 2020 and 2023, average publication date December 2021. Induced Pluripotent Stem Cells, 2 publications between 2021 and 2021, average publication date December 2021. Somatosensory Cortex, 1 publications between 2021 and 2021, average publication date December 2021. Erythromelalgia, 1 publications between 2023 and 2023, average publication date January 2023. Chalazion, 1 publications between 2023 and 2023, average publication date June 2023. Glucocorticoids, 1 publications between 2023 and 2023, average publication date June 2023.

To see the data from this visualization as text, click here.
Alsaloum's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (51)
Explore
_
Co-Authors (1)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.